Osman Metin İPÇİOĞLU, Mustafa GÜLTEPE, Ömer ÖZCAN

2-(5-nitro-2-pyridylazo)-5-(n-propyl-n-sulfopropylamino) phenol (nitro-paps) ve bakır arasındaki reaksiyonu temel alan metodun idrar bakır ölçümü için kullanılarak otomasyona uyarlanması

Aim: To develop a sensitive automated colorimetric urine copper determination method using a water soluble compound, 2-(5-nitro-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino) phenol (nitro-PAPS), as a ligand. Materials and Methods: The new photometric method using sodium dodecyl sulfate (SDS)-ascorbic acid to dissociate copper from proteins in acetate buffer (pH 3.2) and nitro-PAPS as ligand was also adapted to an automated analyzer. Copper concentrations were determined by atomic absorption spectrophotometric method and by photometric method in 24 h urine samples of patients (n = 100) with various types of diseases including Wilson’s disease (n = 12), diabetes mellitus (n = 34), osteoporosis (n = 27), nephrotic syndrome (n = 17), and rheumatoid arthritis (n = 10). Results: There was a statistically significant correlation (P < 0.01) between our new method and the atomic absorption spectrophotometric method (y = 0.994x + 0.207, Sy/x = 1.776), and the photometric method was linear up to 200 μg/l concentration. Other complexing metals (Zn+2 and Fe+2) had no interfering effect on the Cu-nitro-PAPS reaction. The analytical recovery of copper was between 90% and 107% (mean 98%). Within-run and between-run CVs were

A copper determination method based on the reaction between 2-(5-nitro-2-pyridylazo)-5-(n-propyl-n-sulfopropylamino) phenol (nitro-PAPS) and copper for use in urine copper measurement and application to automation

PDF

___

1. Youssef AAR, Wood B, Baron DN. Serum copper: a marker of disease activity in rheumatoid arthritis. J Clin Pathol 1983; 36:14-17
2. Buamah PK, Russell M, Milford-Ward A, Taylor P, Roberts DF. Serum copper concentration significantly less in abnormal pregnancies. Clin Chem 1984; 30: 1676-1677.
3. Lightman A, Brandes JM, Binur N, Drugan A, Zinder O. Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy. Clin Chem 1986; 32: 101-103.
4. Willims HL, Johnson DJ, Haut MJ. Simultaneous spectrophotometry of Fe2+ and Cu2+ in serum denaturated with guanidine hydrochloride. Clin Chem 1977; 23: 237-240.
5. Abe A, Yamashita S, Noma A. Sensitive, direct colorimetric assay for copper in serum. Clin Chem 1989; 35: 552-554.
6. Yamashita S, Abe A, Noma A. Sensitive, direct procedures for simultaneous determinations of iron and copper in serum, with use of 2-(5-Nitro-2-pyridylazo)-5-(N-propyl-N-sulfopropylamino) phenol (Nitro-PAPS) as ligand. Clin Chem 1992; 37: 1373-1375.
7. Makino T, Kyonaga M, Kina K. A sensitive, direct colorimetric assay of serum iron using the chromogen, nitro PAPS. Clin Chim Acta 1988; 171: 19-28.
8. Dawson RMC, Elliott DC, Elliott WH, Jones KM. Data for biochemical research 3rd ed. Oxford: Clarendon Press 1986; p 411.